Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) is 7.46% higher on its value in year-to-date trading and has touched a low of $7.75 and a high of $19.09 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CNTA stock was last observed hovering at around $17.26 in the last trading session, with the day’s gains setting it 0.74%.
Currently trading at $18.00, the stock is 7.28% and 6.59% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.96 million and changing 4.29% at the moment leaves the stock 33.06% off its SMA200. CNTA registered 94.38% gain for a year compared to 6-month gain of 70.62%. The firm has a 50-day simple moving average (SMA 50) of $16.8784 and a 200-day simple moving average (SMA200) of $13.482075.
The stock witnessed a 17.96% loss in the last 1 month and extending the period to 3 months gives it a 9.09%, and is 4.41% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.61% over the week and 7.00% over the month.
Centessa Pharmaceuticals plc ADR (CNTA) has around 76 employees, a market worth around $2.37B and $6.91M in sales. Profit margin for the company is -2344.26%. Distance from 52-week low is 132.26% and -5.71% from its 52-week high. The company has generated returns on investments over the last 12 months (-27.78%).
The EPS is expected to grow by 2.97% this year, but quarterly earnings will post -100.00% year-over-year. Quarterly sales are estimated to shrink -100.00% in year-over-year returns.
The shares outstanding are 131.66M, and float is at 90.14M with Short Float at 3.38%.
The top institutional shareholder in the company is MEDICXI VENTURES MANAGEMENT (JERSEY) LTD with over 19.96 million shares valued at $180.27 million. The investor’s holdings represent 19.9856 of the CNTA Shares outstanding. As of 2024-06-30, the second largest holder is GENERAL ATLANTIC, L.P. with 9.68 million shares valued at $87.43 million to account for 9.6927 of the shares outstanding. The other top investors are ECOR1 CAPITAL, LLC which holds 5.71 million shares representing 5.7208 and valued at over $51.6 million, while FIRST LIGHT ASSET MANAGEMENT, LLC holds 4.7859 of the shares totaling 4.78 million with a market value of $43.17 million.
Centessa Pharmaceuticals plc ADR (CNTA) Insider Activity
The most recent transaction is an insider sale by Anderson Karen M., the company’s Chief People Officer. SEC filings show that Anderson Karen M. sold 30,526 shares of the company’s common stock on Feb 07 ’25 at a price of $19.03 per share for a total of $0.58 million. Following the sale, the insider now owns 54322.0 shares.
Centessa Pharmaceuticals plc ADR disclosed in a document filed with the SEC on Feb 10 ’25 that Anderson Karen M. (Chief People Officer) sold a total of 429 shares of the company’s common stock. The trade occurred on Feb 10 ’25 and was made at $18.99 per share for $8147.0. Following the transaction, the insider now directly holds 54322.0 shares of the CNTA stock.
Still, SEC filings show that on Feb 10 ’25, Anderson Karen M. (Officer) Proposed Sale 429 shares at an average price of $18.99 for $8147.0. The insider now directly holds shares of Centessa Pharmaceuticals plc ADR (CNTA).
